QuidelOrtho provides diagnostic solutions and products aimed at enhancing healthcare through testing capabilities in both at-home and clinical settings. Self-described as offering solutions across the healthcare continuum.

QuidelOrtho

Varex Imaging Corporation designs and manufactures X-ray imaging components. The company operates in two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, 3D reconstruction and computer-aided diagnostic software, collimators, automatic exposure control devices, generators, heat exchangers, ionization chambers, and buckys. This segment's products are used in a range of applications, including radiographic and fluoroscopic imaging, mammography, computed tomography, radiation therapy, oncology, CT, cardiac, surgery, dental, computer-aided detection, and other diagnostic radiography uses. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital detectors, and high voltage connectors for use in security and industrial inspection applications, such as airport security, cargo screening at ports and borders, and nondestructive testing and examination in various applications. Varex Imaging Corporation sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. The company has operations in North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Varex Imaging Corporation was founded in 2016 and is based in Salt Lake City, Utah.

Varex Imaging Corporation

LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. The company also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, it offers valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, the company provides vascular and cardiac patches, which are used for closure of vessels after surgical intervention; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

LeMaitre Vascular, Inc.

Te Whatu Ora Health New Zealand Waikato provides healthcare services to the community. The organization is self-described as a health district aiming to improve the health outcomes for the people of Waikato.

Metric
Company Name	QuidelOrtho	Varex Imaging Corporation	LeMaitre Vascular, Inc.	Te Whatu Ora Health New Zealand Waikato
Symbol		VREX	LMAT
MSH ID	COM:QUIDEL	COM:VAREXIMAGING	COM:LEMAITRE	NZ:HEALTH:WAIKATODHB
Market	PRIVATE	STOCKS	STOCKS	PRIVATE
Sector	Healthcare & Health Services	Healthcare	Healthcare	Healthcare & Health Services
Industry	Medical Devices and Diagnostics	Medical - Devices	Medical - Instruments & Supplies	Healthcare
Country	US	US	US	NZ
Stage
Employee Count		2.30K	614
Website	quidel.com	vareximaging.com	lemaitre.com	waikatodhb.health.nz
LinkedIn
Founders

Metric
Market Cap	574.64M	1.87B
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	811M	193.48M
Revenue (LTM)
Revenue (NTM)
Gross Profit	256.90M	120.96M
EBITDA	67.20M	46.60M
Operating Income	32.10M	37.08M
Net Income	-47.70M	30.11M
EPS	-1.17	1.36
Diluted EPS	-1.17	1.34
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.32	0.67
Operating Profit Margin	0.08	0.22
EBITDA Margin	0.08	0.24
Net Profit Margin	0.05	0.18
Return on Equity	0.08	0.12
Return on Assets	0.04	0.10
Return on Capital Employed	0.06	0.14

QUID

COM:QUIDEL

QuidelOrtho

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	16.24	47.66
P/B Ratio	1.38	4.50
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	0.81	10.18
EV Multiple	5.40	44.55

Metric
Days Sales Outstanding	66.84	46.98
Days Payables Outstanding	39.16	24.28
Days Inventory Outstanding	182.02	342.30
Operating Cycle	248.95	397.01
Cash Conversion Cycle	203.98	386.29
Asset Turnover	0.71	0.57

Metric
Operating Cash Flow	108.40M	36.75M
Free Cash Flow	87.70M	29.49M
Cash Flow to Debt	0.26	15.26
Operating Cash Flow/Sales	0.14	0.20
Free Cash Flow Yield	0.07	0.01

Metric
Cash & Equivalents	168.70M	24.27M
Accounts Receivable	9.80M	-3.13M
Inventory	264.80M	52.33M
Goodwill	291M	65.94M
Debt to Capitalization	0.45	0.06
Debt to Assets	0.38	0.05
Current Ratio	4.04	6.28
Quick Ratio	2.37	5.86

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.02	0.02
R&D to Revenue	0.09	0.09
SG&A to Revenue		0.16